Ortivus AB (publ) (STO:ORTI.A)
Sweden
· Delayed Price · Currency is SEK 2.620
-0.540 (-17.08%)
Apr 22, 2025, 5:29 PM CET
Ortivus AB Revenue
In the year 2024, Ortivus AB had annual revenue of 80.41M SEK, down -4.36%. Ortivus AB had revenue of 21.26M in the quarter ending December 31, 2024, with 13.03% growth.
Revenue
80.41M
Revenue Growth
-4.36%
P/S Ratio
0.83
Revenue / Employee
2.51M
Employees
41
Market Cap
67.07M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 80.41M | -3.67M | -4.36% |
| Dec 31, 2023 | 84.08M | -20.43M | -19.55% |
| Dec 31, 2022 | 104.51M | 10.24M | 10.86% |
| Dec 31, 2021 | 94.27M | -13.31M | -12.37% |
| Dec 31, 2020 | 107.58M | 56.73M | 111.58% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.03B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Camurus AB | 1.87B |
| Medicover AB | 23.97B |
| Vitrolife AB | 3.61B |
| Bonesupport Holding AB | 898.73M |
| Vimian Group AB | 4.29B |